What does working on a NEW indication mean to you? They don’t just continue where they left off at with skin cancer in domestic pets. DIFFERENT indication. NEW unknowns. NEW discoveries. In the near term I’m confident it goes back down if all they do is work towards a NEW indication.
People sell off shares and then want to get back in at .018 or .02 but hey, thats how the OTC works.
$RDGL will do very well as more actual investors come onboard. I like how Dr Korenko is approaching FDA submission and really do think IDE designation is just around the corner.
Market Data 
Markets 
AI
